A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid Arthritis

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2007

Study Completion Date

December 31, 2007

Conditions

Rheumatoid Arthritis

Interventions

DRUG

etanercept

Trial Locations (13)

Goshogawara

Choseigun

Yotsukaidō

Fukuoka

Fukushima

Higashihiroshima

Katoh

Sagamihara

Kumamoto

Sendai

Nagano

Sasebo

Ōita

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00484237 - A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter